<DOC>
	<DOCNO>NCT02260921</DOCNO>
	<brief_summary>This purpose study evaluate effectiveness safety iovera° device temporary reduction pain associate knee osteoarthritis .</brief_summary>
	<brief_title>Study Evaluate Iovera° Device Temporary Relief From Knee Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Inclusion Criteria 35 75 year age American College Rheumatology ( ACR ) criteria osteoarthritis knee . This include radiographic evidence osteophyte least one following : age ≥ 50 year old , morning stiffness ≤ 30 minute duration crepitus motion . Grade II III osteoarthritis knee determine KellgrenLawrence classification grade scale anteroposterior ( AP ) xray within previous 6 month . Subjects ambulatory without assistive device . Knee pain ≥ 40 mm Visual Analog Scale ( VAS ) perform one two movement elicit bad pain : standing seat position walk up/down stair . Subject report knee pain anterior and/or inferior aspect knee document knee pain map appropriate area . A diagnostic lidocaine ( without epinephrine ) block infrapatellar branch saphenous nerve result 50 % reduction VAS pain assessment score performing activity elicit bad pain : standing seat position walk up/down stair . Subject able tolerate washout prescription overthecounter pain relief duration 5X half life medication prior Baseline visit . Subject able tolerate washout adjunctive therapy knee pain 72 hour prior Baseline visit . Western Ontario McMaster Osteoarthritis Index ( WOMAC ) NRS3.1 Pain subscore ≥ 20 Baseline/Visit 2 . Subject able tolerate discontinuation pain medication throughout duration study . Acetaminophen may use rescue medication maximum dose 4g per day . Subject able tolerate discontinuation rescue medication , acetaminophen , 24 hour prior followup visit . Prescription overthecounter pain medication must maintain stable schedule least two week prior screen . Subject willing able give write informed consent . Subject willing able comply study instruction commit followup visit duration study . Subject good general health free systemic disease state physical condition might impair evaluation Investigator 's opinion , expose Subject unacceptable risk study participation . History partial full knee replacement knee treat . Planned partial full knee replacement within next 12 month knee treat . Previous myoscience FCTTM treatment . Viscosupplementation within previous 6 month knee treat . Subject report majority knee pain outside anterior/inferior aspect knee . Intraarticular steroid injection knee treat within previous 3 month . Gross deformity knee include varus valgus . Started physical therapy knee treat within 3 month screen . Received acupuncture knee pain within 3 month prior screen . Body Mass Index ≥ 35 . Prior surgery treatment area may alter anatomy infrapatellar branch saphenous nerve result scar tissue treatment area . Open and/or infect wound treatment area . Disease spine , hip , contralateral knee lower extremity joint sufficient degree affect assessment treat knee . Acetaminophen intolerance allergy . Allergy lidocaine . History cryoglobulinemia History paroxysmal cold hemoglobinuria . History cold urticaria . History Raynaud 's disease . History pes anserinus bursitis knee treat . Use extendedrelease longacting opioids within previous 3 month . Use immediaterelease opioids 3 day per week within previous month . Subject pregnant planning become pregnant enrol study . Current enrollment investigational drug device study participation within 30 day prior screen . Any additional diagnosis opinion Investigator directly contribute knee pain . Any concomitant inflammatory disease condition affect joint ( e.g . rheumatoid arthritis , metabolic bone disease , gout , active infection , etc . ) Any clot disorder and/or use anticoagulant ( e.g. , aspirin , warfarin , clopidogrel , etc . ) within seven ( 7 ) day prior administration device . Any local skin condition treatment site Investigator 's opinion would adversely affect treatment outcomes . Any chronic medical condition Investigator 's opinion would prevent adequate participation . Any chronic medication use ( prescription , overthecounter , etc . ) Investigator 's opinion would affect study participation Subject safety . For reason , opinion Investigator , Subject may suitable candidate study participation ( i.e. , history noncompliance , drug dependency , related knee injury due worker 's compensation claim , etc. ) . Known liver dysfunction .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>